<b>Objective: </b>The use of remote
real-time continuous glucose monitoring (CGM) in the hospital has rapidly
emerged to preserve personal protective equipment (PPE) and reduce potential exposures
during COVID-19.
<p><b>Design and Methods:</b> We linked a hybrid CGM and point-of-care (POC)
glucose testing protocol to a computerized decision support system for
continuous insulin infusion (CII) and integrated a validation system for sensor
glucose values into the electronic health record. We report our
proof-of-concept experience in a COVID-19 ICU.<b></b></p>
<p><b>Results: </b>All nine patients
required mechanical ventilation and corticosteroids. Seventy six percent of
sensor values were within 20% of the reference POC glucose with an associated
average reduction in POC of 63%. Mean time in range (70-180 mg/dL) was 71.4 ± 13.9%.
Sensor accuracy was impacted by mechanical interferences in four patients.</p>
<p><b>Conclusions: </b>A hybrid
protocol integrating real-time CGM and POC is helpful for managing critically
ill patients with COVID-19 requiring insulin infusion. </p>
Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept
